Omlonti (omidenepag isopropyl) is a relatively selective EP2 receptor agonist. It's an eye drop used to lower high pressure in the eyes caused by conditions like open-angle glaucoma or ocular hypertension. The eye drops are placed in the eye once per day in the evening. Side effects include eye redness and sensitivity to light. Omlonti (omidenepag isopropyl) was FDA approved in 2022.
Treatment of high pressure in the eye in adults with:
Omlonti (omidenepag isopropyl) is a relatively selective EP2 receptor agonist. The exact way it works isn't well-understood, but it's thought to lower pressure in the eye by helping fluids flow out of the eye.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
How to use Omlonti (omidenepag isopropyl):
Ask your eye specialist whether Omlonti (omidenepag isopropyl) is available. This medication was initially approved by the FDA in 2022, and the manufacturer planned for it to become available in 2024. But it's unclear whether Omlonti (omidenepag isopropyl) is currently available. If this medication isn't yet on the market, your healthcare team can talk with you about other options for lowering eye pressure.
No, Omlonti (omidenepag isopropyl) isn't FDA approved to treat dry eyes. This medication is only approved to lower eye pressure in people who have open-angle glaucoma or ocular hypertension. In clinical studies, some people reported dry eyes as a side effect after using Omlonti (omidenepag isopropyl). If you have dry eyes, ask your eye specialist about options to treat your symptoms.
If you wear contact lenses, take them out before using Omlonti (omidenepag isopropyl). Then, wait at least 15 minutes after using the medication to put them back into your eye(s).
Yes, you can use other eye drops while you're on Omlonti (omidenepag isopropyl) treatment. But be sure to wait at least 5 minutes between the doses of each medication. This allows time for your eye to fully absorb each medication.
Omlonti (omidenepag isopropyl) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Only put Omlonti (omidenepag isopropyl) eye drops on the surface of the eye. Don't swallow the medication or use the suspension as an injection.
Omlonti (omidenepag isopropyl) can darken the color of your eyes and eyelids. This change in color happens because the medication causes the levels of melanin in your eyes to go up. Melanin is a protein that's responsible for the color of certain parts of your eyes.
The change in color might not be noticeable until after a few months or years of using Omlonti (omidenepag isopropyl). Color changes in the iris (the circular colored part of your eye) are most likely permanent. Your eyelashes and the skin around your eyes might also become darker, but this usually goes away after you stop using the medication. These side effects aren't known to be harmful, but it's best to check in with your eye provider regularly so they can make sure your eyes stay healthy.
During treatment with Omlonti (omidenepag isopropyl), it's possible for your eyelashes to grow in length or thickness. It can also make you have more eyelashes. These changes are typically reversible when you stop the medication.
Prostaglandins like Omlonti (omidenepag isopropyl) can cause or worsen eye inflammation (redness and swelling). This is more likely to happen if you already have eye inflammation or if the lens of your eye is damaged or missing. Talk to your prescriber if you notice eye discomfort or changes in your vision while you're using Omlonti (omidenepag isopropyl).
Omlonti (omidenepag isopropyl) can potentially cause swelling of the retina (also known as macular edema). In clinical studies, this eye condition happened in some people with an artificial lens in their eye(s) who used Omlonti (omidenepag isopropyl). Macular edema can cause changes in vision, such as blurry vision or dull color vision. Your prescriber might give you routine eye exams while taking Omlonti (omidenepag isopropyl) to check your eye health. Contact your prescriber if you notice any changes in vision while using the medication.
Avoid touching the tip of the Omlonti (omidenepag isopropyl) bottle to your eyes when you're using the eye drops. Doing so can contaminate the eye drops and raise your risk of infection or eye injury.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 2.5ml of 0.002% | 1 eye dropper | $342.25 | $342.25 |
Adults: The typical dose is 1 drop in the affected eye(s) once per day in the evening.
Treatment of high pressure in the eye in adults with: